Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

Defining workplace culture, elevating customer service and strengthening collaboration have been the name of the game for ...

BOTTOM LINE: The New York Mets host the Philadelphia Phillies on Monday to begin a three-game series. New York has a 69-61 ...

Vanderpump Rules' star Scheana Shay is reacting to Peter Madrigal saying that he doesn't like the former members of the show.

Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...

George Lopez, Jesse Garcia and Al Madrigal are among the new additions to the one-night-only virtual table read of the 2007 ...

Highlights,Madrigal Pharmaceuticals shows strong share movement in recent weeks,Revenue growth remains uneven across short- ...

The world-renowned Philippine Madrigal Singers (MADZ) will take centre stage for a live performance at the Thailand Cultural ...

BOTTOM LINE: The New York Mets will look to sweep a three-game series with a win against the Atlanta Braves. Atlanta has a 32 ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

MDGL wins EU nod for Rezdiffra as the first and only approved MASH therapy. The drug's launch in Europe is expected in the fourth quarter of 2025.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.